Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Medicine and Dentistry
Apoplexy
100%
Transient Ischemic Attack
66%
Vertebral Artery Dissection
60%
Cerebral Hemorrhage
54%
Antithrombotic
54%
Hemodynamic
53%
Brain Ischemia
52%
Acetylsalicylic Acid
45%
Anticoagulation
39%
Magnetic Resonance Imaging
36%
Bypass Surgery
33%
Limb
30%
Prospective Cohort Study
30%
Tenecteplase
30%
Central Retinal Artery Occlusion
30%
Sex Differences
30%
Fluid Attenuated Inversion Recovery
26%
Hematoma
24%
National Institutes of Health Stroke Scale
23%
Best Corrected Visual Acuity
22%
Infarction
22%
Randomized Controlled Trial
21%
Carotid Artery Stenosis
21%
Diffusion MRI
20%
Vitamin K Antagonist
20%
Gray Matter
19%
Odds Ratio
19%
Morbidity
16%
Oxygen 15
15%
Positron Emission Tomography
15%
Perfusion Weighted Imaging
15%
Revascularization
15%
Elderly Patient
15%
Paroxysmal Atrial Fibrillation
15%
Tissue Plasminogen Activator
15%
Susceptibility Weighted Imaging
15%
Arterial Spin Labeling
15%
Thrombus
15%
Vertebral Artery
15%
Noninferiority Trial
15%
Recurrent Disease
15%
Patient-Data
15%
Meta-Analysis
15%
Systematic Review
15%
Dysautonomia
15%
Treatment Effect
15%
Extraintracranial Anastomosis
15%
Vascular Disease
15%
Autonomic Dysfunction
15%
Placebo
14%
Keyphrases
Intracerebral Hemorrhage
60%
Oral Anticoagulants
60%
Cervical Artery Dissection (CeAD)
60%
Transient Ischemic Attack
59%
Anticoagulation
51%
Aspirin
48%
Limb Shaking
37%
Cerebral Hemodynamics
35%
Modified Rankin Scale
33%
Vitamin K Antagonists
30%
Sex Differences
30%
Moyamoya Disease
30%
Randomized Trial
30%
Tenecteplase
30%
Central Retinal Artery Occlusion
30%
Ischemic Stroke
29%
Antithrombotic Therapy
27%
Hemodynamic Insufficiency
25%
Risk Factors
24%
Hemodynamic Failure
22%
Randomized Controlled Trial
22%
Best-corrected Visual Acuity
22%
Acetazolamide
20%
Bypass Patency
19%
Subgroup Analysis
19%
Extracranial-intracranial Bypass
18%
Symptom Onset
18%
Denmark
17%
Perfusion
17%
95% Confidence Interval
17%
EC-IC Bypass
17%
Stroke Prevention
17%
Capital Region
16%
Cerebrovascular Hemodynamics
16%
Odds Ratio
16%
Acute Ischemic Stroke
16%
Fluid-attenuated Inversion Recovery (FLAIR)
15%
Acute Stroke
15%
Signal Intensity
15%
Comorbidity
15%
Stroke Ischemic
15%
Stroke Risk
15%
Clinical Significance
15%
Ultrasound
15%
Tissue Plasminogen Activator (t-PA)
15%
Treatment Effect
15%
Pivotal Trial
15%
6-month Follow-up
15%
Long-term Stroke
15%
Trends in Incidence
15%
